O
Ocugen, Inc.
OCGN · NASDAQ · Healthcare · 458M
Price · close
$1.39
+0.00% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
—
Enterprise value / EBITDAEV/EBITDA
-7.2×
Free cash flow yieldFCF yield
-13.7%
Return on equityROE
557.7%
Operating margin
-1425.7%
Net debt / EBITDAbalance-sheet strength
-0.2×
Interest coverage
-12.1×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.